Please assess the completion status of the following clinical trial:

Trial Title: Dynamic CT Myocardial Perfusion Imaging

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Referral for cardiac hybrid imaging with CCTA and SPECT~* Male and Female subjects 18 years of age or older,~* Written informed consent by the participant after information about the project~Exclusion Criteria:~* Contraindications for CCTA (including renal failure with a GFR \<60ml/min/1.73m2, allergies to ionidated constrast agents)~* Inability to follow the examination procedure due to language barriers, mental disease, dementia etc.~* Pregnancy or breast feeding~* Known allergies to iodinated contrast agent (Visipaque ®), 99mTc-Tetrofosmin (Myoview ®), betablockers (Beloc i.v. ®) or nitrates (Isoket -Spray®)~* Hypersensitivity to adenosine~* Asthma bronchiale

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CTP and SPECT-MPI (Type: OTHER): Every patient enrolled will undergo CT-MPI and SPECT-MPI. The latter is clinically indicated,.

Based on this trial design, predict the completion outcome and termination type (if applicable).